Literature DB >> 20109044

Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management.

Stanford T Shulman1, Robert R Tanz.   

Abstract

Group A streptococcal pharyngitis remains the most important bacterial pharyngitis because of its frequency and potential complications. Group A streptococcal pharyngitis is most common in children 5-11 years of age in winter-spring, and a rapid test or culture is necessary for accurate diagnosis. We propose a management strategy for those geographic areas with very low acute rheumatic fever rates, emphasizing selective testing that avoids testing those patients with viral-like features (e.g., rhinorrhea and cough). Acute rheumatic fever is the most important immune-mediated sequela and has become rare in most areas of the USA and Western Europe, most probably due to decreased circulation of highly rheumatogenic group A streptococcal strains.

Entities:  

Mesh:

Year:  2010        PMID: 20109044     DOI: 10.1586/eri.09.134

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  14 in total

Review 1.  The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Authors:  Alexander V Dmitriev; Michael S Chaussee
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

2.  A dramatic decline in university hospital admissions of acute rheumatic fever in the eastern region of Saudi Arabia.

Authors:  Mohammed Fakhry Abdul-Mohsen; Amer A Lardhi
Journal:  J Saudi Heart Assoc       Date:  2011-01-08

3.  Evaluation of Simplexa Group A Strep Direct Kit Compared to Hologic Group A Streptococcal Direct Assay for Detection of Group A Streptococcus in Throat Swabs.

Authors:  Deirdre L Church; Tracie Lloyd; Oscar Larios; Daniel B Gregson
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

4.  Detection of Group A Streptococcus in Pharyngeal Swab Specimens by Use of the AmpliVue GAS Isothermal Helicase-Dependent Amplification Assay.

Authors:  Matthew L Faron; Nathan A Ledeboer; Paul Granato; Judy A Daly; Kristina Pierce; Preeti Pancholi; Timothy S Uphoff; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

5.  Impact of technical training on rapid antigen detection tests (RADT) in group A streptococcal tonsillopharyngitis.

Authors:  N Toepfner; P Henneke; R Berner; M Hufnagel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-04       Impact factor: 3.267

Review 6.  A systematic review of Fusobacterium necrophorum-positive acute tonsillitis: prevalence, methods of detection, patient characteristics, and the usefulness of the Centor score.

Authors:  T E Klug; M Rusan; K Fuursted; T Ovesen; A W Jorgensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-27       Impact factor: 3.267

Review 7.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 8.  Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a "protein homeostasis system".

Authors:  Kyung-Yil Lee; Jung-Woo Rhim; Jin-Han Kang
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

9.  A randomized controlled study of 5 and 10 days treatment with phenoxymethylpenicillin for pharyngotonsillitis caused by streptococcus group A - a protocol study.

Authors:  Gunilla Skoog; Charlotta Edlund; Christian G Giske; Sigvard Mölstad; Christer Norman; Pär-Daniel Sundvall; Katarina Hedin
Journal:  BMC Infect Dis       Date:  2016-09-13       Impact factor: 3.090

10.  Transfer of scarlet fever-associated elements into the group A Streptococcus M1T1 clone.

Authors:  Nouri L Ben Zakour; Mark R Davies; Yuanhai You; Jonathan H K Chen; Brian M Forde; Mitchell Stanton-Cook; Ruifu Yang; Yujun Cui; Timothy C Barnett; Carola Venturini; Cheryl-lynn Y Ong; Herman Tse; Gordon Dougan; Jianzhong Zhang; Kwok-Yung Yuen; Scott A Beatson; Mark J Walker
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.